SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-177752
Filing Date
2024-07-11
Accepted
2024-07-11 16:49:34
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d761813ds3.htm S-3 268360
2 EX-4.2 d761813dex42.htm EX-4.2 29377
3 EX-4.3 d761813dex43.htm EX-4.3 262569
4 EX-5.1 d761813dex51.htm EX-5.1 27138
5 EX-23.1 d761813dex231.htm EX-23.1 1909
6 EX-FILING FEES d761813dexfilingfees.htm EX-FILING FEES 28807
7 GRAPHIC g761813g74d25.jpg GRAPHIC 72567
8 GRAPHIC g761813g90f62.jpg GRAPHIC 8721
  Complete submission text file 0001193125-24-177752.txt   731782
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-3 | Act: 33 | File No.: 333-280759 | Film No.: 241112512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)